NCT04549103 is a NA clinical trial of Baduanjin exercise program in Frailty, sponsored by Geriatric Education and Research Institute.

Who is sponsoring NCT04549103?

NCT04549103 is sponsored by Geriatric Education and Research Institute.

What drugs are being tested in NCT04549103?

Interventions in NCT04549103: Baduanjin exercise program.

What condition does NCT04549103 study?

NCT04549103 studies Frailty, Frail Elderly Syndrome.

Is NCT04549103 still recruiting?

NCT04549103 is currently completed. Last updated 2 February 2024.

Last reviewed 2024-02-02 · How we verify

NCT04549103

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Baduanjin on Functional Performance in Pre-Frail/Frail Older Adults

Completed NA Last updated 2 February 2024

What this trial tests

NA trial testing Baduanjin exercise program in Frailty in 58 participants. Completed in 14 November 2023.

Timeline

30 April 2021

Primary endpoint
14 November 2023

14 November 2023

Quick facts

Lead sponsor	Geriatric Education and Research Institute
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	58
Start date	30 April 2021
Primary completion	14 November 2023
Estimated completion	14 November 2023
Sites	1 location across Singapore

Drugs / interventions tested

Baduanjin exercise program

Conditions studied

Frailty — all drugs for Frailty →
Frail Elderly Syndrome — all drugs for Frail Elderly Syndrome →

Sponsor

Geriatric Education and Research Institute

Who can join

55 and older, any sex, with Frailty or Frail Elderly Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim for this study is to investigate the effectiveness of a 16-week realistic community-delivered Baduanjin training program compared to a waitlist control intervention, in improving functional outcomes among pre-frail and frail older adults in Singapore. It is hypothesized that participants that receive 16-week of BDJ training will have significant improvement in physical function (including balance, muscle strength, and endurance); alleviate exhaustion; reduce risk of falling and fear of falling; potentially reverse frailty; reduce depression; and improve quality of life, potentially with greater improvements in area(s) for individuals with lower baseline measures. Whereas, participants in the waitlist control group, will have insignificant changes to their baseline measures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effectiveness of community-based Baduanjin exercise intervention for older adults with varying frailty status: a randomized controlled trial.
Tou NX, Goh SF, Harding S, Tsao MA, et al · · 2024 · cited 10× · PMID 39390362 · DOI 10.1186/s11556-024-00363-6

Verify or expand the search:

Other trials of Baduanjin exercise program

Trials testing the same drug.

NCT04430309 — Baduanjin on Patients With Schizophrenia · NA · completed

Other recruiting trials for Frailty

Currently open trials in the same condition.

NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
NCT07519603 — Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program · NA · recruiting
NCT07144527 — Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults · NA · recruiting
NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home · NA · recruiting
NCT07475767 — Ultrasound Indicators of Nutritional Status and Treatment Outcomes in Surgical Patients in the Intensive Care Unit · recruiting

Other Geriatric Education and Research Institute trials

Trials by the same sponsor.

NCT06753643 — An Intrinsic Capacity Identification and Management Programme for Older Adults in Singapore's Primary Care · not yet recruiting
NCT05756478 — Appropriate Prescribing for Older Adults With Multimorbidity (Pro-M) · NA · completed
NCT04788251 — Falls Prevention Evaluation and Development for Older Adults in the Community · NA · completed
NCT04866316 — Protocol for Multi-site Evaluation of New Community-based Frailty Programme · completed
NCT04438876 — The Effects of Functional Power Training on Frail and Pre-frail Community - Dwelling Older Adults in Singapore · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04549103 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Geriatric Education and Research Institute
Last refreshed: 2 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04549103.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing